Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Anne Fuhlbrigge

Concepts (429)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Asthma
98
2025
1797
9.670
 Why?
Anti-Asthmatic Agents
28
2025
260
3.310
 Why?
Adrenal Cortex Hormones
28
2025
484
3.260
 Why?
Forced Expiratory Volume
19
2019
450
1.520
 Why?
Pulmonary Disease, Chronic Obstructive
11
2022
920
1.350
 Why?
Severity of Illness Index
20
2020
2933
0.940
 Why?
Administration, Inhalation
25
2025
571
0.930
 Why?
Anti-Inflammatory Agents
10
2016
478
0.840
 Why?
Albuterol
5
2015
76
0.810
 Why?
Bronchodilator Agents
12
2016
187
0.810
 Why?
Lung Transplantation
10
2017
332
0.780
 Why?
Budesonide
14
2016
49
0.780
 Why?
Remote Consultation
4
2025
66
0.720
 Why?
Nedocromil
11
2016
20
0.690
 Why?
Humans
129
2025
145763
0.670
 Why?
Nasal Polyps
1
2021
59
0.670
 Why?
Self Report
3
2023
876
0.660
 Why?
Endpoint Determination
2
2020
85
0.650
 Why?
Pharmacogenetics
2
2015
175
0.650
 Why?
Food Hypersensitivity
1
2022
164
0.620
 Why?
Sinusitis
1
2021
227
0.580
 Why?
Virus Diseases
1
2021
216
0.560
 Why?
Glucocorticoids
4
2022
532
0.550
 Why?
Lung
7
2019
4116
0.550
 Why?
Physicians
2
2021
956
0.540
 Why?
Symptom Assessment
1
2019
136
0.530
 Why?
Hospitalization
13
2020
2460
0.520
 Why?
Sleep Apnea, Obstructive
1
2021
303
0.510
 Why?
Androstadienes
3
2012
77
0.500
 Why?
Bone Density
2
2014
487
0.490
 Why?
Child
53
2022
22739
0.480
 Why?
Disease Progression
14
2020
2865
0.480
 Why?
Oxygen Inhalation Therapy
4
2020
181
0.480
 Why?
Managed Care Programs
8
2008
140
0.470
 Why?
Male
82
2025
73003
0.450
 Why?
Precision Medicine
1
2020
461
0.450
 Why?
Adult
47
2025
40872
0.440
 Why?
Emergency Service, Hospital
9
2013
2383
0.440
 Why?
Adrenergic beta-2 Receptor Agonists
4
2020
26
0.430
 Why?
Cost Savings
1
2015
86
0.430
 Why?
Female
81
2025
79035
0.420
 Why?
Practice Patterns, Physicians'
7
2020
1372
0.420
 Why?
Patient Reported Outcome Measures
1
2018
498
0.410
 Why?
Peak Expiratory Flow Rate
2
2011
25
0.390
 Why?
Cost-Benefit Analysis
7
2022
644
0.390
 Why?
Phenotype
6
2025
3170
0.380
 Why?
Middle Aged
40
2025
36302
0.380
 Why?
Comorbidity
4
2021
1662
0.350
 Why?
Academic Medical Centers
3
2024
554
0.340
 Why?
Surveys and Questionnaires
14
2022
6085
0.330
 Why?
Adolescent
37
2019
22573
0.320
 Why?
Medical Records Systems, Computerized
3
2008
95
0.320
 Why?
Administration, Oral
6
2021
867
0.320
 Why?
Mentors
1
2012
217
0.320
 Why?
Respiratory Function Tests
10
2015
544
0.310
 Why?
Quality of Life
12
2023
3210
0.310
 Why?
United States
23
2022
16123
0.300
 Why?
Interprofessional Relations
3
2021
276
0.300
 Why?
Faculty, Medical
1
2012
305
0.290
 Why?
Spirometry
8
2020
233
0.290
 Why?
Child, Preschool
31
2016
11868
0.290
 Why?
Child Development
1
2014
483
0.290
 Why?
Treatment Outcome
16
2025
11793
0.290
 Why?
Group Practice
1
2008
6
0.280
 Why?
Anti-Allergic Agents
2
2008
40
0.270
 Why?
Oxygen
3
2018
981
0.270
 Why?
Computer Simulation
1
2012
1003
0.270
 Why?
Aged
22
2022
26215
0.260
 Why?
Dyspnea
3
2022
250
0.250
 Why?
Drug Utilization
4
2005
168
0.240
 Why?
Randomized Controlled Trials as Topic
8
2020
1751
0.240
 Why?
Primary Health Care
5
2025
1737
0.240
 Why?
Primary Graft Dysfunction
2
2017
33
0.230
 Why?
Quality Assurance, Health Care
1
2008
342
0.230
 Why?
Follow-Up Studies
17
2017
5428
0.230
 Why?
Bronchiolitis Obliterans
3
2017
61
0.230
 Why?
Respiratory Sounds
1
2006
103
0.230
 Why?
Gift Giving
1
2005
9
0.230
 Why?
Diagnostic Techniques, Respiratory System
1
2005
5
0.230
 Why?
Allergists
2
2022
13
0.220
 Why?
Genetic Testing
1
2008
483
0.220
 Why?
Delivery of Health Care
2
2021
947
0.220
 Why?
Specialization
2
2025
137
0.200
 Why?
Medication Adherence
2
2023
540
0.200
 Why?
Cohort Studies
14
2013
6032
0.200
 Why?
Retrospective Studies
18
2024
17325
0.200
 Why?
Natural Language Processing
1
2025
106
0.200
 Why?
Time Factors
10
2020
7133
0.200
 Why?
Massachusetts
5
2016
180
0.200
 Why?
Leadership
2
2022
402
0.200
 Why?
Antibodies, Monoclonal
2
2008
1505
0.200
 Why?
Medicine
1
2025
125
0.190
 Why?
Genetic Variation
1
2008
976
0.190
 Why?
Rhinitis, Allergic, Perennial
1
2003
20
0.190
 Why?
Steroids
8
2011
160
0.190
 Why?
Recurrence
5
2013
1139
0.190
 Why?
Genetic Predisposition to Disease
2
2025
2399
0.180
 Why?
Health Status
1
2008
835
0.180
 Why?
Predictive Value of Tests
9
2012
2123
0.180
 Why?
Beclomethasone
1
2022
8
0.180
 Why?
Models, Theoretical
4
2007
560
0.180
 Why?
Multicenter Studies as Topic
4
2018
413
0.180
 Why?
Young Adult
11
2019
14251
0.180
 Why?
Prevalence
4
2022
2874
0.170
 Why?
Tiotropium Bromide
2
2018
5
0.170
 Why?
Desensitization, Immunologic
1
2022
89
0.170
 Why?
Nebulizers and Vaporizers
2
2020
62
0.170
 Why?
Biomarkers
3
2021
4302
0.170
 Why?
Social Class
2
2022
264
0.170
 Why?
Patient Preference
1
2023
223
0.160
 Why?
Churg-Strauss Syndrome
1
2020
27
0.160
 Why?
Bronchoconstriction
3
2011
29
0.160
 Why?
Pulmonologists
1
2020
14
0.160
 Why?
Granulomatosis with Polyangiitis
1
2020
47
0.160
 Why?
Capacity Building
1
2021
62
0.160
 Why?
Muscarinic Antagonists
1
2020
30
0.160
 Why?
Agammaglobulinemia
1
2020
36
0.160
 Why?
Physician-Patient Relations
2
2021
588
0.150
 Why?
Air Pollution, Indoor
2
2002
171
0.150
 Why?
Electronic Health Records
2
2025
1202
0.150
 Why?
Practice Guidelines as Topic
5
2020
1582
0.150
 Why?
Risk Factors
12
2018
10917
0.150
 Why?
Treatment Adherence and Compliance
1
2019
27
0.140
 Why?
Exercise Test
1
2022
630
0.140
 Why?
Receptors, IgE
2
2009
43
0.140
 Why?
Allergens
1
2021
386
0.130
 Why?
Prognosis
8
2017
4329
0.130
 Why?
Vitamin D
2
2012
404
0.130
 Why?
Fossil Fuels
1
1997
9
0.130
 Why?
Hypersensitivity
1
2020
254
0.130
 Why?
Alemtuzumab
1
2017
15
0.130
 Why?
Photopheresis
1
2017
9
0.130
 Why?
Drug Prescriptions
2
2011
288
0.130
 Why?
Respiration
1
2017
207
0.130
 Why?
Biological Products
1
2020
257
0.130
 Why?
Physicians, Primary Care
3
2021
208
0.120
 Why?
Respiration Disorders
1
1997
78
0.120
 Why?
Emergency Medical Services
2
2007
684
0.120
 Why?
Statistics, Nonparametric
1
2017
428
0.120
 Why?
Drug Therapy, Combination
5
2020
1043
0.120
 Why?
Drug Combinations
3
2012
396
0.120
 Why?
Immunomodulation
1
2017
99
0.120
 Why?
Socioeconomic Factors
4
2022
1327
0.120
 Why?
Drug Monitoring
1
2020
401
0.120
 Why?
Tobacco Smoke Pollution
2
2010
227
0.120
 Why?
Scopolamine Derivatives
1
2015
3
0.120
 Why?
Breath Tests
2
2008
77
0.120
 Why?
Immunoglobulin G
1
2020
892
0.120
 Why?
Embolism, Fat
1
2015
11
0.120
 Why?
Aged, 80 and over
6
2019
8346
0.110
 Why?
Patient Admission
1
2018
220
0.110
 Why?
Cholinergic Antagonists
1
2015
24
0.110
 Why?
Transplants
1
2015
38
0.110
 Why?
National Heart, Lung, and Blood Institute (U.S.)
1
2015
103
0.110
 Why?
Fluticasone-Salmeterol Drug Combination
2
2012
7
0.110
 Why?
Carcinoma, Bronchogenic
1
2015
20
0.110
 Why?
Genomics
2
2018
830
0.110
 Why?
Longitudinal Studies
6
2017
2967
0.110
 Why?
Referral and Consultation
1
2021
868
0.100
 Why?
Graft Rejection
2
2013
521
0.100
 Why?
Respiratory Tract Infections
2
2012
396
0.100
 Why?
Overweight
2
2011
614
0.100
 Why?
Ambulatory Care Information Systems
2
2005
5
0.100
 Why?
Prednisolone
1
2014
67
0.100
 Why?
Postoperative Complications
2
2017
2977
0.100
 Why?
Risk
4
2015
923
0.100
 Why?
Telemedicine
1
2023
966
0.100
 Why?
Guideline Adherence
3
2020
587
0.100
 Why?
Education, Medical, Continuing
2
2005
134
0.100
 Why?
Airway Obstruction
1
2015
153
0.100
 Why?
Environmental Exposure
3
2006
578
0.100
 Why?
Forecasting
1
2015
390
0.100
 Why?
Bronchial Hyperreactivity
3
2010
104
0.100
 Why?
Transplantation
1
2013
33
0.100
 Why?
Office Visits
4
2011
93
0.090
 Why?
Quality Improvement
1
2022
1296
0.090
 Why?
Insurance Claim Review
1
2013
83
0.090
 Why?
Growth
1
2012
49
0.090
 Why?
Research
1
2015
431
0.090
 Why?
Peer Group
2
2012
256
0.090
 Why?
Costs and Cost Analysis
1
2013
221
0.090
 Why?
Medicare
2
2022
904
0.090
 Why?
Double-Blind Method
5
2010
2064
0.090
 Why?
Methacholine Chloride
3
2008
51
0.090
 Why?
Metered Dose Inhalers
1
2012
8
0.090
 Why?
Cytomegalovirus Infections
2
2012
206
0.090
 Why?
Cost of Illness
3
2003
324
0.090
 Why?
Drug Dosage Calculations
1
2011
27
0.090
 Why?
Feedback
1
2012
180
0.090
 Why?
Logistic Models
5
2017
2139
0.090
 Why?
Mycoses
1
2012
88
0.090
 Why?
Antibodies, Monoclonal, Humanized
2
2008
992
0.090
 Why?
Antifungal Agents
1
2012
152
0.090
 Why?
Effect Modifier, Epidemiologic
1
2011
8
0.090
 Why?
Multivariate Analysis
7
2017
1547
0.080
 Why?
Body Height
1
2012
203
0.080
 Why?
Medication Errors
1
2012
85
0.080
 Why?
Professional Role
1
2012
170
0.080
 Why?
Morbidity
2
2022
322
0.080
 Why?
Mycobacterium
1
2012
101
0.080
 Why?
Epidemiologic Studies
1
2011
68
0.080
 Why?
Pneumococcal Vaccines
1
2012
129
0.080
 Why?
Obesity
3
2015
3118
0.080
 Why?
Diagnostic Errors
1
2012
178
0.080
 Why?
Program Development
1
2012
368
0.080
 Why?
Patient Readmission
1
2016
772
0.080
 Why?
Secondary Prevention
1
2012
251
0.080
 Why?
Drug Resistance
1
2011
145
0.080
 Why?
Probability
1
2011
308
0.080
 Why?
Lung Diseases
1
2017
782
0.080
 Why?
Vitamin D Deficiency
1
2012
190
0.080
 Why?
Chi-Square Distribution
2
2017
528
0.080
 Why?
Bronchial Provocation Tests
2
2008
47
0.080
 Why?
Fluticasone
2
2008
53
0.080
 Why?
Pragmatic Clinical Trials as Topic
2
2020
133
0.080
 Why?
Immunoglobulin E
2
2008
315
0.070
 Why?
Vital Capacity
4
2017
292
0.070
 Why?
Incidence
5
2020
2933
0.070
 Why?
Receptors, Corticotropin-Releasing Hormone
1
2009
30
0.070
 Why?
Lectins, C-Type
1
2009
59
0.070
 Why?
Decision Support Techniques
2
2012
480
0.070
 Why?
Ambulatory Care
2
2011
610
0.070
 Why?
Smoking
3
2017
1477
0.070
 Why?
Algorithms
1
2017
1850
0.070
 Why?
Health Services
2
2007
113
0.070
 Why?
Medication Therapy Management
1
2010
72
0.070
 Why?
Proportional Hazards Models
1
2012
1330
0.070
 Why?
Odds Ratio
4
2017
1083
0.070
 Why?
Health Knowledge, Attitudes, Practice
2
2012
1420
0.070
 Why?
Surgical Wound Infection
1
2012
329
0.070
 Why?
Pandemics
3
2022
1711
0.070
 Why?
Acute Disease
1
2011
1036
0.070
 Why?
Kaplan-Meier Estimate
3
2016
971
0.070
 Why?
Vitamin K Epoxide Reductases
1
2008
12
0.070
 Why?
Cytochrome P-450 CYP2C9
1
2008
20
0.070
 Why?
Eosinophil Cationic Protein
1
2008
9
0.070
 Why?
Cross-Sectional Studies
6
2010
5922
0.070
 Why?
Mixed Function Oxygenases
1
2008
43
0.070
 Why?
Adrenergic beta-Agonists
1
2008
92
0.070
 Why?
Program Evaluation
1
2012
944
0.070
 Why?
Aryl Hydrocarbon Hydroxylases
1
2008
45
0.070
 Why?
Genetic Techniques
1
2008
66
0.070
 Why?
Quality-Adjusted Life Years
2
2006
125
0.070
 Why?
Insurance, Pharmaceutical Services
1
2008
24
0.070
 Why?
State Health Plans
1
2008
28
0.070
 Why?
Markov Chains
2
2006
132
0.070
 Why?
Cost Sharing
1
2008
20
0.070
 Why?
Smoking Cessation
1
2012
441
0.070
 Why?
Trastuzumab
1
2008
118
0.070
 Why?
Reimbursement Mechanisms
1
2008
79
0.070
 Why?
Antibodies, Anti-Idiotypic
1
2007
50
0.070
 Why?
Mycobacterium Infections, Nontuberculous
1
2012
339
0.070
 Why?
Chronic Disease
3
2017
1812
0.060
 Why?
Omalizumab
1
2007
43
0.060
 Why?
Exercise Tolerance
2
2022
283
0.060
 Why?
Factor Analysis, Statistical
1
2008
291
0.060
 Why?
Health Surveys
2
2006
520
0.060
 Why?
Influenza Vaccines
1
2012
534
0.060
 Why?
Interviews as Topic
1
2011
916
0.060
 Why?
Warfarin
1
2008
179
0.060
 Why?
Antiviral Agents
1
2012
769
0.060
 Why?
Animals, Domestic
1
2006
17
0.060
 Why?
Databases, Factual
1
2012
1491
0.060
 Why?
Tomography, X-Ray Computed
1
2017
2770
0.060
 Why?
Lung Diseases, Interstitial
1
2013
664
0.060
 Why?
Health Services Accessibility
2
2021
1101
0.060
 Why?
Animals
2
2025
38097
0.060
 Why?
Physicians, Family
2
2004
177
0.060
 Why?
Eosinophils
1
2008
316
0.060
 Why?
Biomedical Research
1
2012
719
0.060
 Why?
Health Benefit Plans, Employee
1
2005
25
0.060
 Why?
Models, Biological
1
2012
1764
0.050
 Why?
Database Management Systems
1
2005
51
0.050
 Why?
Hip Fractures
1
2006
87
0.050
 Why?
Health Policy
1
2008
400
0.050
 Why?
Patients
1
2006
183
0.050
 Why?
Insurance Coverage
1
2006
244
0.050
 Why?
Utilization Review
1
2004
39
0.050
 Why?
Infant
3
2008
10090
0.050
 Why?
Body Mass Index
3
2015
2447
0.050
 Why?
Patient Education as Topic
3
2005
777
0.050
 Why?
Gene Expression Profiling
1
2011
1777
0.050
 Why?
Prenatal Exposure Delayed Effects
1
2010
655
0.050
 Why?
Clinical Competence
1
2012
1247
0.050
 Why?
Medicaid
1
2008
467
0.050
 Why?
Nitric Oxide
1
2008
892
0.050
 Why?
Vaccination
1
2012
1428
0.050
 Why?
Attitude to Health
1
2006
430
0.050
 Why?
Mass Screening
1
2012
1361
0.050
 Why?
Sex Factors
3
2016
2110
0.050
 Why?
Anticoagulants
1
2008
748
0.050
 Why?
Case Management
1
2003
68
0.050
 Why?
Choice Behavior
1
2004
180
0.050
 Why?
Clinical Trials as Topic
2
2005
1062
0.050
 Why?
Puerto Rico
1
2022
63
0.050
 Why?
Parents
3
2006
1407
0.050
 Why?
Symptom Flare Up
1
2022
37
0.040
 Why?
Anti-Bacterial Agents
2
2004
1925
0.040
 Why?
Sputum
1
2004
302
0.040
 Why?
Circadian Rhythm
1
2006
513
0.040
 Why?
Academies and Institutes
1
2022
61
0.040
 Why?
Health Services Research
1
2004
391
0.040
 Why?
Lung Neoplasms
1
2015
2667
0.040
 Why?
Minority Groups
1
2003
285
0.040
 Why?
Survival Rate
2
2016
2094
0.040
 Why?
Clinical Trials, Phase II as Topic
1
2020
75
0.040
 Why?
Electronics
1
2021
65
0.040
 Why?
Clinical Trials, Phase III as Topic
1
2020
116
0.040
 Why?
Sample Size
1
2020
121
0.040
 Why?
Efficiency
1
2021
103
0.040
 Why?
Health Care Reform
1
2021
109
0.040
 Why?
Schools, Medical
1
2021
159
0.040
 Why?
Patient Compliance
2
2016
588
0.040
 Why?
Risk Assessment
3
2020
3752
0.040
 Why?
Patient Selection
2
2020
739
0.040
 Why?
Language
1
2022
324
0.040
 Why?
Stress, Psychological
1
2007
1149
0.040
 Why?
Time
1
2019
84
0.040
 Why?
Cluster Analysis
2
2014
501
0.040
 Why?
Health Education
1
2002
346
0.040
 Why?
Quality of Health Care
1
2003
693
0.030
 Why?
Poland
1
2017
34
0.030
 Why?
Bronchitis, Chronic
1
2017
16
0.030
 Why?
Republic of Korea
1
2017
43
0.030
 Why?
Cooperative Behavior
1
2021
463
0.030
 Why?
Patient-Centered Care
1
2003
547
0.030
 Why?
Sensitivity and Specificity
3
2013
2000
0.030
 Why?
Nitrogen Dioxide
1
1997
45
0.030
 Why?
Geography
1
2018
187
0.030
 Why?
Aftercare
1
2019
222
0.030
 Why?
Monitoring, Physiologic
2
2012
289
0.030
 Why?
Self Concept
1
2019
254
0.030
 Why?
Netherlands
1
2016
84
0.030
 Why?
Long-Term Care
1
2018
118
0.030
 Why?
Antineoplastic Agents
1
2008
2219
0.030
 Why?
Tuberculosis, Pulmonary
1
2017
127
0.030
 Why?
Pediatrics
1
2005
1125
0.030
 Why?
Forced Expiratory Flow Rates
1
2015
10
0.030
 Why?
Formoterol Fumarate
1
2015
6
0.030
 Why?
Salmeterol Xinafoate
1
2015
20
0.030
 Why?
Perception
1
2019
378
0.030
 Why?
Ethanolamines
1
2015
14
0.030
 Why?
Receptors, Adrenergic, beta-2
1
2015
36
0.030
 Why?
Treatment Failure
1
2016
360
0.030
 Why?
Dose-Response Relationship, Drug
2
2011
2028
0.030
 Why?
Education
1
2015
105
0.030
 Why?
Self Efficacy
1
2019
413
0.030
 Why?
Postoperative Period
1
2016
351
0.030
 Why?
Polymorphism, Single Nucleotide
2
2016
2181
0.030
 Why?
Feasibility Studies
1
2020
1115
0.030
 Why?
Immunosuppressive Agents
2
2015
838
0.030
 Why?
Age Factors
3
2008
3346
0.030
 Why?
Fatal Outcome
1
2015
305
0.030
 Why?
Biopsy
2
2013
1082
0.030
 Why?
Pilot Projects
1
2020
1897
0.030
 Why?
Combined Modality Therapy
1
2017
1270
0.030
 Why?
Patient Acceptance of Health Care
1
2021
883
0.030
 Why?
Gene Expression
1
2018
1478
0.020
 Why?
Telephone
2
2005
177
0.020
 Why?
Echinocandins
1
2012
8
0.020
 Why?
Lipopeptides
1
2012
17
0.020
 Why?
Aspergillosis
1
2012
24
0.020
 Why?
Amphotericin B
1
2012
36
0.020
 Why?
Intention to Treat Analysis
1
2012
79
0.020
 Why?
Candidiasis
1
2012
64
0.020
 Why?
Tissue Donors
1
2015
420
0.020
 Why?
Transplantation, Homologous
1
2013
419
0.020
 Why?
Mycobacterium avium Complex
1
2012
87
0.020
 Why?
Age Distribution
2
2003
404
0.020
 Why?
Cromolyn Sodium
2
2001
6
0.020
 Why?
Hypoxia
1
2019
1199
0.020
 Why?
Leukotriene Antagonists
1
2011
24
0.020
 Why?
Extracorporeal Membrane Oxygenation
1
2015
390
0.020
 Why?
Triazoles
1
2012
191
0.020
 Why?
Self Care
2
2005
392
0.020
 Why?
Functional Residual Capacity
1
2010
7
0.020
 Why?
Reference Values
1
2012
798
0.020
 Why?
Colorado
1
2021
4556
0.020
 Why?
Costa Rica
1
2010
18
0.020
 Why?
Nontuberculous Mycobacteria
1
2012
189
0.020
 Why?
Principal Component Analysis
1
2011
194
0.020
 Why?
Health
1
2010
82
0.020
 Why?
Inhalation
1
2010
29
0.020
 Why?
Genome-Wide Association Study
1
2016
1430
0.020
 Why?
Environment
1
2011
293
0.020
 Why?
Observation
1
2008
54
0.020
 Why?
Sex Ratio
1
2008
17
0.020
 Why?
Least-Squares Analysis
1
2008
73
0.020
 Why?
Models, Econometric
1
2008
35
0.020
 Why?
Prospective Studies
2
2012
8075
0.020
 Why?
Health Services Administration
1
2007
9
0.020
 Why?
Treatment Refusal
1
2008
99
0.020
 Why?
Intelligence
1
2007
115
0.020
 Why?
Social Isolation
1
2007
74
0.020
 Why?
Puberty
1
2008
137
0.020
 Why?
Body Weight
1
2011
972
0.020
 Why?
Child Behavior Disorders
1
2007
119
0.020
 Why?
Exercise
1
2016
2205
0.010
 Why?
Genotype
1
2009
1857
0.010
 Why?
CD4-Positive T-Lymphocytes
1
2011
1146
0.010
 Why?
Insurance, Health
1
2007
311
0.010
 Why?
Bronchoconstrictor Agents
1
2003
14
0.010
 Why?
Organizational Innovation
1
2004
119
0.010
 Why?
Health Status Indicators
1
2004
167
0.010
 Why?
Case-Control Studies
1
2010
3634
0.010
 Why?
Systems Integration
1
2003
36
0.010
 Why?
Computer Systems
1
2003
55
0.010
 Why?
Motor Activity
1
2007
718
0.010
 Why?
Histamine H1 Antagonists
1
2002
24
0.010
 Why?
Drug Administration Schedule
1
2004
782
0.010
 Why?
Self Disclosure
1
2002
61
0.010
 Why?
Child Welfare
1
2004
233
0.010
 Why?
Administration, Intranasal
1
2002
94
0.010
 Why?
Confidence Intervals
1
2002
330
0.010
 Why?
Regression Analysis
1
2003
1001
0.010
 Why?
Nurse's Role
1
2003
149
0.010
 Why?
Point-of-Care Systems
1
2003
189
0.010
 Why?
Health Care Surveys
1
2002
536
0.010
 Why?
Sex Distribution
1
2001
388
0.010
 Why?
Patient Satisfaction
1
2004
712
0.010
 Why?
Linear Models
1
2002
849
0.010
 Why?
Disease Management
1
2003
653
0.010
 Why?
Decision Support Systems, Clinical
1
2003
273
0.010
 Why?
Bronchoscopy
1
2000
227
0.010
 Why?
Caregivers
1
2007
1074
0.010
 Why?
Internet
1
2003
693
0.010
 Why?
Pregnancy
1
2010
7215
0.010
 Why?
Survival Analysis
1
2000
1378
0.010
 Why?
Infant, Newborn
1
2004
6464
0.010
 Why?
Fuhlbrigge's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (429) concept(s)
_
Co-Authors Expand Description
See all (16) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)